OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ)

CUSIP: 686164302

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / COM NEW
Total 13F shares
6,346,678
Share change
+5,523,665
Total reported value
$21,071,400
Put/Call ratio
3425%
Price per share
$3.32
Number of holders
38
Value change
+$20,714,400
Number of buys
37
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 686164302?
CUSIP 686164302 identifies OREXQ - OREXIGEN THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) as of Q3 2016

As of 30 Sep 2016, OREXIGEN THERAPEUTICS INC - COM NEW (OREXQ) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,346,678 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, BVF INC/IL, SAMLYN CAPITAL, LLC, VANGUARD GROUP INC, MORGAN STANLEY, NEA Management Company, LLC, CREDIT SUISSE AG/, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and Palo Alto Investors, LLC. This page lists 38 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.